| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGA | Common Stock | Options Exercise | $55,861 | +433 | $129.01 | 433 | 07 Nov 2023 | Direct | ||
| transaction | RGA | Common Stock | Tax liability | $29,770 | -192 | -44% | $155.05 | 241 | 07 Nov 2023 | Direct | F1 |
| transaction | RGA | Common Stock | Options Exercise | $51,454 | +483 | +200% | $106.53 | 724 | 07 Nov 2023 | Direct | |
| transaction | RGA | Common Stock | Tax liability | $33,181 | -214 | -30% | $155.05 | 510 | 07 Nov 2023 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGA | Stock Appreciation Right (right to purchase) 2021 | Options Exercise | $0 | -2,576 | -50% | $0.000000 | 2,577 | 07 Nov 2023 | Common Stock | 2,576 | $129.01 | Direct | F3 |
| transaction | RGA | Stock Appreciation Right (right to purchase) 2022 | Options Exercise | $0 | -1,546 | -25% | $0.000000 | 4,641 | 07 Nov 2023 | Common Stock | 1,546 | $106.53 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Represents (i) 2,143 shares sold to pay the exercise price the purchase of common stock, and (ii) 192 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 241 shares. |
| F2 | Represents (i) 1,063 shares sold to pay the exercise price the purchase of common stock, and (ii) 214 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 269 shares. |
| F3 | SARs grants vest in 25% increments over four years, starting on December 31 of the year of grant. |